PMID- 2960035
OWN - NLM
STAT- MEDLINE
DCOM- 19871124
LR  - 20131121
IS  - 0385-0005 (Print)
IS  - 0385-0005 (Linking)
VI  - 11
IP  - 5
DP  - 1986 Nov
TI  - Clinical effect of dipyridamole in patients with IgA nephropathy.
PG  - 329-33
AB  - Clinical effects of dipyridamole and carbazochrome sodium sulfonate in patients 
      with IgA nephropathy are described. Oral administration of 300 mg of dipyridamole 
      and 180 mg of carbazochrome sodium sulfonate per day was employed in the present 
      study. Urinalysis and renal function tests, i.e. serum creatinine (s-Cr), blood 
      urea nitrogen (BUN), glomerular filtration rate (GFR) and phenolsulfonphtalein 
      (PSP) tests, were performed before and after the administration of dipyridamole. 
      It was demonstrated that the administration of dipyridamole was effective in 
      reducing the level of proteinuria in the patients. The administration of 
      carbazochrome sodium sulfonate was not effective in reducing the proteinuria 
      level. It was concluded that the administration of dipyridamole may be useful for 
      treatment of patients with IgA nephropathy.
FAU - Yagame, M
AU  - Yagame M
AD  - Department of Internal Medicine, School of Medicine, Tokai University, Japan.
FAU - Tomino, Y
AU  - Tomino Y
FAU - Miura, M
AU  - Miura M
FAU - Suga, T
AU  - Suga T
FAU - Endoh, M
AU  - Endoh M
FAU - Nomoto, Y
AU  - Nomoto Y
FAU - Sakai, H
AU  - Sakai H
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PL  - Japan
TA  - Tokai J Exp Clin Med
JT  - The Tokai journal of experimental and clinical medicine
JID - 7704186
RN  - 64ALC7F90C (Dipyridamole)
RN  - 70G54NQL71 (Adrenochrome)
RN  - 81F061RQS4 (carbazochrome)
SB  - IM
MH  - Adrenochrome/analogs & derivatives/therapeutic use
MH  - Dipyridamole/*therapeutic use
MH  - Glomerulonephritis/drug therapy
MH  - Glomerulonephritis, IGA/*drug therapy
MH  - Hematuria/drug therapy
MH  - Humans
MH  - Proteinuria/drug therapy
EDAT- 1986/11/01 00:00
MHDA- 1986/11/01 00:01
CRDT- 1986/11/01 00:00
PHST- 1986/11/01 00:00 [pubmed]
PHST- 1986/11/01 00:01 [medline]
PHST- 1986/11/01 00:00 [entrez]
PST - ppublish
SO  - Tokai J Exp Clin Med. 1986 Nov;11(5):329-33.